Internet claims on dietary and herbal supplements in advanced nephropathy: truth or myth.
Am J Nephrol
; 40(5): 393-8, 2014.
Article
en En
| MEDLINE
| ID: mdl-25376340
ABSTRACT
BACKGROUND:
The use of complementary/alternative medicine has garnered rising interest in recent years. Natural products including herbs, vitamins, and minerals are the most popularly consumed. The Internet is a ubiquitous source of information/market for these supplements.AIM:
To systematically evaluate the dietary and herbal supplement recommended for patients with CKD and ESRD on the Internet, and try to distinguish between the claim of the manufacturer and proven scientific data.METHODS:
A questionnaire assessing each website was formulated. Each product ingredient was recorded in the questionnaire by two independent reviewers and statistically analyzed.RESULTS:
Of the 184 websites, 28% claimed to decrease CKD progression, 60% did not advise to consult a doctor before taking the supplement, and >90% did not mention any potential drug interaction, disease interaction, or caution in use during pregnancy or in children. The ten common plant ingredients claiming to be beneficial in kidney diseases were uva ursi, dandelion, parsley, corn silk, juniper, celery, buchu, horsetail, marshmallow, and stinging nettle. In contrast to their claims, these substances were not adequately studied in humans. The available animal studies showed detrimental effects and potential drug interactions with commonly used medications in the CKD/ESRD population.CONCLUSIONS:
Nephrologists need to be cognizant of the lack of substantiated proven benefits of these substances and of the potential adverse effects in the animal models that can translate to the patients. Most importantly, the policy needs to change regarding the regulation of these products to prevent patient harm and misinformation.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Comunicación
/
Suplementos Dietéticos
/
Internet
/
Preparaciones de Plantas
/
Interacciones Farmacológicas
/
Información de Salud al Consumidor
/
Fallo Renal Crónico
Tipo de estudio:
Prognostic_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Am J Nephrol
Año:
2014
Tipo del documento:
Article
País de afiliación:
Estados Unidos